<DOC>
	<DOCNO>NCT00976521</DOCNO>
	<brief_summary>This multicenter , open-label , control , single-blind , randomize study 452 subject enrol 50 US European site . Subjects present anterior ST-elevation myocardial infarction ( STEMI ) occlude proximal mid leave anterior descending ( LAD ) TIMI 0/1/2 flow eligible randomization one follow arm : 1 . Local infusion abciximab follow thrombus aspiration 2 . Local infusion abciximab thrombus aspiration 3 . No local infusion thrombus aspiration 4 . No local infusion thrombus aspiration In addition , cardiac magnetic resonance imaging ( MRI ) sub-study evaluate microvascular obstruction ( MVO ) perform 160 subject 20 site .</brief_summary>
	<brief_title>The INFUSE - Anterior Myocardial Infarction ( AMI ) Study</brief_title>
	<detailed_description>The primary objective study demonstrate among subject undergo primary PCI anterior STEMI treat bivalirudin monotherapy anticoagulation strategy , intracoronary infusion abciximab bolus without thrombus aspiration prior stent implantation , compare infusion without thrombus aspiration ( standard care ) , result 1 ) reduce infarct size measure cardiac MRI 30 day ( range -7 days/+14 day ; i.e. , 23 44 day ) , 2 ) reduce microvascular obstruction ( MVO ) cardiac MRI 5 + 2 day ( i.e. , 3 7 day ) , 3 ) enhance ST-segment resolution , 4 ) improve myocardial perfusion , 5 ) reduce thrombus burden angiographic complication , 6 ) increase major minor bleeding .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Anterior Wall Myocardial Infarction</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<criteria>Key The subject must &gt; 18 year age ; Subject experience clinical symptom consistent AMI ( e.g. , chest pain , arm pain , etc. , ) &gt; 30 minute duration unresponsive nitroglycerin ; Anterior MI ECG show least 1 mm STsegment elevation 2 contiguous lead V1V4 , new ( presumably new ) leave bundle branch block ; Anticipated symptom onset balloon aspiration time ≤5 hour ; The subject his/her physician willing comply specify followup evaluation ; The subject legally authorize representative inform nature study , agree provision provide sign write informed consent , approve appropriate Medical Ethics Committee ( MEC ) Institutional Review Board ( IRB ) Infarct artery locate proximal mid leave anterior descend coronary artery , TIMI 0/1/2 flow time initial diagnostic angiography ( prior wire passage ) ; Based coronary anatomy , PCI indicate revascularization ; Only one epicardial coronary artery treat ; Expected ability deliver ClearWay™ RX Infusion Catheter infarct lesion ( absence excessive tortuosity , diffuse disease moderate/heavy calcification ) . Key Prior myocardial infarction , know prior systolic dysfunction ( know ejection fraction &lt; 40 % prior measure regional wall motion abnormality ) ; An elective surgical procedure plan would necessitate interruption antiplatelet agent first twelve month post enrollment ; Subjects previously underwent coronary stent implantation coronary angiography demonstrate stent thrombosis cause AMI ; Subject previously undergone angioplasty stenting procedure leave anterior descending artery ; Definite plan use aspiration , atherectomy , thrombectomy and/or distal protection catheter prior PTCA stent implantation ( subject randomize thrombus aspiration ) ; Any contraindication undergo MRI imaging . Multivessel intervention require index procedure ( subject may enrol treatment one lesion LAD branch require , however ) ( plan stag procedure permit strong recommendation perform 30day clinical MRI endpoint complete ) ; Severe vessel tortuosity , diffuse disease severe calcification present may impede successful delivery ClearWay™ RX Infusion Catheter Export® Aspiration Catheter ; Features present highly unfavorable PCI ; Target lesion present within bypass graft conduit ; MI due thrombosis within adjacent previously implant stent ; Left ventriculography demonstrate severe mitral regurgitation VSD ; Unprotected leave main stenosis &gt; 40 % require intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>